• Gastroretentive Sponges for Alfuzosin HCl: Design and MRI Ev

  2026-04-23

  This study introduces low-density gastroretentive sponges as a novel delivery system for Alfuzosin HCl, aiming to sustain drug release and enhance oral bioavailability. Using a factorial design, the research evaluates formulation parameters, in vitro performance, and in vivo gastric retention by MRI, with implications for optimizing α1 adrenoceptor antagonist therapy in BPH.

• Azathramycin A: Advancing Macrolide Strategies in TB Researc

  2026-04-22

  Azathramycin A, a potent macrolide antibiotic and ribosome inhibitor specific to Mycobacterium tuberculosis, is redefining translational research approaches in tuberculosis. This article synthesizes mechanistic insights, experimental best practices, and competitive benchmarking to provide actionable guidance for researchers leveraging Azathramycin A in infection models and antibiotic resistance studies.

• GRK Subtype Bias in M1 Muscarinic Receptor Signaling Decoded

  2026-04-22

  This study systematically dissects how different GRK subtypes regulate signaling bias at the M1 muscarinic acetylcholine receptor, revealing distinct roles for GRK2/3 and GRK5/6 in modulating downstream G protein and β-arrestin binding. The findings clarify the molecular underpinnings of biased signaling, informing both drug safety and efficacy strategies in cognitive and Alzheimer's disease research.

• ARCA Cy5 EGFP mRNA (5-moUTP): Optimizing mRNA Delivery Assay

  2026-04-21

  Leverage ARCA Cy5 EGFP mRNA (5-moUTP) for precise, dual-mode quantification of mRNA delivery and translation in mammalian cells. This workflow-ready, 5-methoxyuridine modified mRNA enables robust, reproducible localization and efficiency assays, minimizing innate immune activation.

• Meropenem Trihydrate: Carbapenem Antibiotic for Resistance S

  2026-04-21

  Meropenem trihydrate empowers researchers to dissect antibacterial mechanisms and resistance phenotypes with precision, especially in high-throughput and metabolomics-driven workflows. Its unmatched solubility and broad-spectrum action make it indispensable for modeling infections and optimizing therapeutic strategies in the lab.

• miR-18a–ALOXE3 Axis Regulates Ferroptosis in Glioblastoma

  2026-04-20

  This study uncovers how the microRNA miR-18a directly suppresses ALOXE3, reducing ferroptosis and enhancing migration in glioblastoma cells. The findings highlight the miR-18a/ALOXE3 pathway as a critical regulator of both cell death and tumor invasiveness, offering a potential new direction for targeted glioblastoma therapies.

• Forsythoside E: Mechanistic Insights and Protocol Precision

  2026-04-20

  Explore the advanced molecular mechanisms of Forsythoside E, a potent pyruvate kinase M2 (PKM2) inhibitor, with practical guidance on assay setup, dosing, and real-world applications. This article uniquely integrates breakthrough findings on STAT3 pathway modulation, setting a new standard for sepsis-induced liver injury research.

• Cy3 Goat Anti-Human IgG (H+L) Antibody in Advanced Immunoass

  2026-04-19

  Harness the Cy3 Goat Anti-Human IgG (H+L) Antibody for robust immunofluorescence, IHC, flow cytometry, and ELISA workflows. Discover optimized protocols, troubleshooting strategies, and translational insights inspired by leading-edge orthopoxvirus research.

• L-Ornithine in Urea Cycle Research: Advanced Workflows & Ins

  2026-04-18

  L-Ornithine, as supplied by APExBIO, empowers precise studies of urea cycle intermediates and ammonia detoxification pathways. This guide translates recent mechanistic findings into actionable protocols and troubleshooting strategies for metabolic and neurotoxicity research.

• Alfuzosin HCl Protocols: Optimizing α1 Adrenoceptor Antagoni

  2026-04-17

  Alfuzosin HCl, a selective α1 adrenoceptor antagonist, empowers precise modeling of lower urinary tract smooth muscle relaxation and BPH pathology. This guide dissects advanced workflows, troubleshooting, and protocol parameters, enabling reproducible, high-fidelity urinary tract research with APExBIO’s rigorously characterized Alfuzosin Hydrochloride.

• Dacarbazine (SKU A2197): Reliable Solutions for Cancer Assay

  2026-04-16

  Discover how Dacarbazine (SKU A2197) provides reproducible, data-backed solutions for cell viability, proliferation, and cytotoxicity assays in cancer research. This scenario-driven guide addresses real laboratory challenges, emphasizing practical workflow improvements and vendor reliability for biomedical researchers.

• Applied Use of EdU Flow Cytometry Assay Kits (Cy3) in Cell C

  2026-04-15

  EdU Flow Cytometry Assay Kits (Cy3) empower researchers with denaturation-free, multiplexed S-phase detection for high-throughput cell proliferation and genotoxicity testing. This article translates the latest mechanistic findings from bladder cancer research into practical assay strategies, with stepwise workflow optimizations and troubleshooting tips to maximize reproducibility and data quality.

• Stattic and STAT3: Strategic Leverage in Translational Oncol

  2026-04-14

  Explore how APExBIO’s Stattic uniquely empowers translational cancer researchers to dissect STAT3 signaling, optimize radiosensitization, and address the evolving interplay between tumor biology and the microbiome. This thought-leadership article synthesizes mechanistic insight, robust experimental validation, and strategic guidance—framing Stattic as both a technical asset and a catalyst for next-generation oncology breakthroughs.

• Cell Cycle Assay Kit: Precision Analysis of Cell Cycle Phase

  2026-04-13

  The Cell Cycle Assay Kit (K2263) from APExBIO empowers researchers to dissect cell cycle phases and apoptosis with high specificity via PI-based flow cytometry. Its robust performance is validated in advanced cancer research, including mechanistic studies of ALK-positive anaplastic large cell lymphoma.

• Thiazovivin (A5506) in Stem Cell Reprogramming and Survival

  2026-04-12

  Thiazovivin is a ROCK inhibitor designed to enhance induced pluripotent stem cell generation and improve human embryonic stem cell survival, especially after dissociation events like trypsinization. It is not intended for diagnostic or therapeutic applications and should not be used outside validated research workflows.

457 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page